Thompson Siegel & Walmsley’s Solventum SOLV Stock Holding History

Thompson Siegel & Walmsley’s Portfolio SOLV Stock Details SOLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-64,362	Closed	-$4.89M	–	421
2025 Q1	$4.89M	Sell	64,362 -47,575	-43%	-$3.54M	0.08%	191
2024 Q4	$7.39M	Buy	111,937 +1,218	+1%	+$85.3K	0.11%	160
2024 Q3	$7.72M	Buy	+110,719	New	+$6.66M	0.12%	157

Other funds holding SOLV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TFM

Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Thompson Siegel & Walmsley's SOLV Position: Q2 2025 in Review

Thompson Siegel & Walmsley sold out of Solventum (SOLV) in Q2 2025, closing a stake of 64,362 shares — an estimated $4.89M sold.

Thompson Siegel & Walmsley first reported a position in SOLV in Q3 2024 and held it in 3 quarters. The position peaked at $7.72M in Q3 2024. 891 funds tracked by Wall St. Rank hold SOLV as of Q2 2025.

Thompson Siegel & Walmsley reported no remaining Solventum position as of Q2 2025 after selling out during the quarter.
Thompson Siegel & Walmsley sold 64,362 Solventum shares in Q2 2025, an estimated $4.89M.
Thompson Siegel & Walmsley first reported a position in Solventum in Q3 2024 and held it in 3 quarters.
Thompson Siegel & Walmsley's Solventum position peaked at $7.72M in Q3 2024.
891 funds tracked by Wall St. Rank held Solventum as of Q2 2025.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2025, filed 6 Aug 2025.